Guided Therapeutics
Norcross
About Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices to enhance healthcare. Its technology, including products in research and development, primarily relates to biophotonics technology for the non-invasive detection of cancers. The company is developing LuViva, a non-invasive cervical cancer detection device; and extension of its cancer detection technology into other cancers, primarily esophageal. The company’s LuViva device would identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. Guided Therapeutics, Inc. has agreements with Konica Minolta, Inc. for the development of non-invasive esophageal cancer detection product based on its biophotonic technology platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $17.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: otcpink:GTHP
- Website: guidedinc.com
- Phone: 7702428639
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/guided-therapeutics-123740 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.